HEALTHYWAY INC (02587) Income Statement & Earnings

4.390
-0.080-1.79%

Market Closed Apr 24 16:07 CST

3.84BMarket Cap61.83P/E (TTM)

HEALTHYWAY INC (02587) Income Statement

All

YOY

Hide blank lines

(FY)Dec 31, 2025

(Q6)Jun 30, 2025

(FY)Dec 31, 2024

(Q6)Jun 30, 2024

(FY)Dec 31, 2023

(Q6)Jun 30, 2023

(FY)Dec 31, 2022

(Q6)Jun 30, 2022

(FY)Dec 31, 2021

(FY)Dec 31, 2020

Turnover

30.13%1.56B

-15.31%517.85M

-3.51%1.2B

14.51%611.49M

118.68%1.24B

86.45%534.01M

31.94%569.07M

--286.41M

131.18%431.31M

--186.57M

Operating income

30.13%1.56B

-15.31%517.85M

-3.51%1.2B

14.51%611.49M

118.68%1.24B

86.45%534.01M

31.94%569.07M

286.41M

131.18%431.31M

186.57M

Cost of sales

-30.11%-1.09B

16.76%-356.12M

1.34%-834.86M

-18.85%-427.82M

-161.77%-846.22M

-145.83%-359.96M

-25.38%-323.27M

---146.43M

-248.36%-257.83M

---74.01M

Operating expenses

-30.11%-1.09B

16.76%-356.12M

1.34%-834.86M

-18.85%-427.82M

-161.77%-846.22M

-145.83%-359.96M

-25.38%-323.27M

-146.43M

-248.36%-257.83M

-74.01M

Gross profit

30.17%476.29M

-11.94%161.73M

-8.12%365.91M

5.52%183.66M

62.02%398.24M

24.34%174.05M

41.69%245.8M

139.98M

54.12%173.47M

112.56M

Selling expenses

9.98%-182.95M

11.49%-87.25M

4.03%-203.22M

-26.07%-98.58M

-43.64%-211.75M

16.65%-78.19M

-16.67%-147.41M

---93.81M

-285.71%-126.35M

---32.76M

Administrative expenses

-24.66%-67.34M

9.76%-26.26M

32.29%-54.02M

22.69%-29.1M

-93.66%-79.78M

-75.54%-37.64M

61.42%-41.2M

---21.44M

-251.14%-106.78M

---30.41M

Research and development expenses

-74.29%-169.03M

30.73%-37.39M

6.21%-96.98M

-48.40%-53.97M

-90.04%-103.4M

-6.64%-36.37M

-284.74%-54.41M

---34.1M

-19.06%-14.14M

---11.88M

Special items of operating profit

147.12%5.07M

155.16%1.16M

-46.82%2.05M

147.74%455K

-52.64%3.86M

36.30%-953K

10.58%8.14M

---1.5M

-38.14%7.36M

--11.9M

Operating profit

351.54%62.05M

385.01%12M

91.93%13.74M

-88.16%2.48M

-34.41%7.16M

292.41%20.9M

116.43%10.92M

-10.86M

-234.47%-66.44M

49.41M

Financing cost

47.20%-2.37M

41.49%-1.36M

-37.77%-4.48M

-45.15%-2.32M

-106.21%-3.25M

-145.62%-1.6M

-36.03%-1.58M

---651K

34.90%-1.16M

---1.78M

Share of profits of associates

-28.32%-367K

53.02%-148K

-297.22%-286K

-321.83%-315K

-108.08%-72K

362.96%142K

895.54%891K

---54K

76.32%-112K

---473K

Special items of earning before tax

----

16.01%-272.77M

50.45%-62.99M

-21.26%-324.78M

-83.24%-127.13M

-217.45%-267.83M

---69.38M

20.32%-84.37M

---105.88M

Earning before tax

122.49%59.32M

116.62%10.5M

17.81%-263.8M

41.36%-63.15M

-24.59%-320.95M

-33.03%-107.69M

-69.38%-257.61M

-80.95M

-158.97%-152.08M

-58.73M

Tax

7.09%-4.98M

-158.86%-3.46M

-175.87%-5.36M

150.21%5.88M

259.26%7.06M

150.85%2.35M

160.98%1.97M

--936K

51.16%-3.22M

---6.6M

After-tax profit from continuing operations

120.19%54.34M

112.29%7.04M

14.25%-269.16M

45.63%-57.28M

-22.78%-313.88M

-31.65%-105.34M

-64.60%-255.64M

-80.01M

-137.73%-155.31M

-65.33M

Earning after tax

120.19%54.34M

112.29%7.04M

14.25%-269.16M

45.63%-57.28M

-22.78%-313.88M

-31.65%-105.34M

-64.60%-255.64M

-80.01M

-137.73%-155.31M

-65.33M

Minority profit

-91.45%-1.34M

98.22%-26K

81.54%-702K

59.30%-1.46M

-252.61%-3.8M

26.34%-3.58M

30.06%2.49M

---4.86M

1,212.33%1.92M

--146K

Profit attributable to shareholders

120.74%55.68M

112.66%7.07M

13.42%-268.46M

45.15%-55.82M

-20.12%-310.08M

-35.40%-101.76M

-64.18%-258.13M

-75.15M

-140.13%-157.22M

-65.47M

Basic earnings per share

115.79%0.06

112.50%0.01

13.64%-0.38

-0.08

-0.44

Diluted earnings per share

115.79%0.06

112.50%0.01

13.64%-0.38

-0.08

-0.44

Currency Unit

CNY

Accounting Standards

IAS

Audit Opinions

Unqualified Opinion

Auditor

KPMG

	(FY)Dec 31, 2025	(Q6)Jun 30, 2025	(FY)Dec 31, 2024	(Q6)Jun 30, 2024	(FY)Dec 31, 2023	(Q6)Jun 30, 2023	(FY)Dec 31, 2022	(Q6)Jun 30, 2022	(FY)Dec 31, 2021	(FY)Dec 31, 2020
Turnover	30.13%1.56B	-15.31%517.85M	-3.51%1.2B	14.51%611.49M	118.68%1.24B	86.45%534.01M	31.94%569.07M	--286.41M	131.18%431.31M	--186.57M
Operating income	30.13%1.56B	-15.31%517.85M	-3.51%1.2B	14.51%611.49M	118.68%1.24B	86.45%534.01M	31.94%569.07M	286.41M	131.18%431.31M	186.57M
Cost of sales	-30.11%-1.09B	16.76%-356.12M	1.34%-834.86M	-18.85%-427.82M	-161.77%-846.22M	-145.83%-359.96M	-25.38%-323.27M	---146.43M	-248.36%-257.83M	---74.01M
Operating expenses	-30.11%-1.09B	16.76%-356.12M	1.34%-834.86M	-18.85%-427.82M	-161.77%-846.22M	-145.83%-359.96M	-25.38%-323.27M	-146.43M	-248.36%-257.83M	-74.01M
Gross profit	30.17%476.29M	-11.94%161.73M	-8.12%365.91M	5.52%183.66M	62.02%398.24M	24.34%174.05M	41.69%245.8M	139.98M	54.12%173.47M	112.56M
Selling expenses	9.98%-182.95M	11.49%-87.25M	4.03%-203.22M	-26.07%-98.58M	-43.64%-211.75M	16.65%-78.19M	-16.67%-147.41M	---93.81M	-285.71%-126.35M	---32.76M
Administrative expenses	-24.66%-67.34M	9.76%-26.26M	32.29%-54.02M	22.69%-29.1M	-93.66%-79.78M	-75.54%-37.64M	61.42%-41.2M	---21.44M	-251.14%-106.78M	---30.41M
Research and development expenses	-74.29%-169.03M	30.73%-37.39M	6.21%-96.98M	-48.40%-53.97M	-90.04%-103.4M	-6.64%-36.37M	-284.74%-54.41M	---34.1M	-19.06%-14.14M	---11.88M
Special items of operating profit	147.12%5.07M	155.16%1.16M	-46.82%2.05M	147.74%455K	-52.64%3.86M	36.30%-953K	10.58%8.14M	---1.5M	-38.14%7.36M	--11.9M
Operating profit	351.54%62.05M	385.01%12M	91.93%13.74M	-88.16%2.48M	-34.41%7.16M	292.41%20.9M	116.43%10.92M	-10.86M	-234.47%-66.44M	49.41M
Financing cost	47.20%-2.37M	41.49%-1.36M	-37.77%-4.48M	-45.15%-2.32M	-106.21%-3.25M	-145.62%-1.6M	-36.03%-1.58M	---651K	34.90%-1.16M	---1.78M
Share of profits of associates	-28.32%-367K	53.02%-148K	-297.22%-286K	-321.83%-315K	-108.08%-72K	362.96%142K	895.54%891K	---54K	76.32%-112K	---473K
Special items of earning before tax	----	----	16.01%-272.77M	50.45%-62.99M	-21.26%-324.78M	-83.24%-127.13M	-217.45%-267.83M	---69.38M	20.32%-84.37M	---105.88M
Earning before tax	122.49%59.32M	116.62%10.5M	17.81%-263.8M	41.36%-63.15M	-24.59%-320.95M	-33.03%-107.69M	-69.38%-257.61M	-80.95M	-158.97%-152.08M	-58.73M
Tax	7.09%-4.98M	-158.86%-3.46M	-175.87%-5.36M	150.21%5.88M	259.26%7.06M	150.85%2.35M	160.98%1.97M	--936K	51.16%-3.22M	---6.6M
After-tax profit from continuing operations	120.19%54.34M	112.29%7.04M	14.25%-269.16M	45.63%-57.28M	-22.78%-313.88M	-31.65%-105.34M	-64.60%-255.64M	-80.01M	-137.73%-155.31M	-65.33M
Earning after tax	120.19%54.34M	112.29%7.04M	14.25%-269.16M	45.63%-57.28M	-22.78%-313.88M	-31.65%-105.34M	-64.60%-255.64M	-80.01M	-137.73%-155.31M	-65.33M
Minority profit	-91.45%-1.34M	98.22%-26K	81.54%-702K	59.30%-1.46M	-252.61%-3.8M	26.34%-3.58M	30.06%2.49M	---4.86M	1,212.33%1.92M	--146K
Profit attributable to shareholders	120.74%55.68M	112.66%7.07M	13.42%-268.46M	45.15%-55.82M	-20.12%-310.08M	-35.40%-101.76M	-64.18%-258.13M	-75.15M	-140.13%-157.22M	-65.47M
Basic earnings per share	115.79%0.06	112.50%0.01	13.64%-0.38	-0.08	-0.44
Diluted earnings per share	115.79%0.06	112.50%0.01	13.64%-0.38	-0.08	-0.44
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	IAS	IAS	IAS	IAS	IAS	IAS	IAS	IAS	IAS	IAS
Audit Opinions	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion	Unqualified Opinion
Auditor	KPMG	--	KPMG	--	KPMG	--	KPMG	--	KPMG	KPMG

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More

牛牛課堂

Oct 13, 2025 18:05

[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?

Food流油

Apr 14, 2025 15:43

"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"